pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 8·1 min read
save

Trump administration seeks lasting overhaul of federal science policy after court setbacks

Jul 8, 2026·read at STAT ↗RegulatoryNegative

The White House has introduced a proposal to cement its authority over federal research contracts, allowing the executive branch to direct research, end grants, and control external scientific reviews.

The move follows a series of actions in the first year of the Trump administration that included firing many federal civil servants, terminating numerous research projects, and pressuring universities to drop diversity initiatives, many of which were quickly challenged in court under the Administrative Procedures Act.

Legal challenges forced the administration to retreat on several policies, but the new Office of Management and Budget proposal aims to make the changes more durable, according to experts who say future administrations could still revert them.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Trump administration pursues more durable changes to science policy after setbacks in court”

read at STAT ↗
499 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoHow voters feel about trans rights and abortion access will soon be put to the testSTAT
  • 1h agoSTAT+: Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospitalSTAT
  • 4h agoSTAT+: Launch prices for new medicines dipped slightly last year but remain high, analysis findsSTAT
  • 6h agoOpinion: Resident physicians may lose some of their most important work hour protectionsSTAT
  • 6h agoSTAT+: The key health care ballot measures we’re watching in the midtermsSTAT